
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Review of Real‐World Implementation Data on Emtricitabine‐Tenofovir Disoproxil Fumarate as HIV Pre‐exposure Prophylaxis in the United States
Jessica Adams, Karishma Shelley, Melanie R. Nicol
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2019) Vol. 39, Iss. 4, pp. 486-500
Open Access | Times Cited: 22
Jessica Adams, Karishma Shelley, Melanie R. Nicol
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2019) Vol. 39, Iss. 4, pp. 486-500
Open Access | Times Cited: 22
Showing 22 citing articles:
Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review
Kenneth H. Mayer, Allison L. Agwu, David J. Malebranche
Advances in Therapy (2020) Vol. 37, Iss. 5, pp. 1778-1811
Open Access | Times Cited: 303
Kenneth H. Mayer, Allison L. Agwu, David J. Malebranche
Advances in Therapy (2020) Vol. 37, Iss. 5, pp. 1778-1811
Open Access | Times Cited: 303
Pharmacy-Based Interventions to Increase Use of HIV Pre-exposure Prophylaxis in the United States: A Scoping Review
Alice Zhao, Derek T. Dangerfield, Amy Nunn, et al.
AIDS and Behavior (2021) Vol. 26, Iss. 5, pp. 1377-1392
Open Access | Times Cited: 51
Alice Zhao, Derek T. Dangerfield, Amy Nunn, et al.
AIDS and Behavior (2021) Vol. 26, Iss. 5, pp. 1377-1392
Open Access | Times Cited: 51
Roles for Pharmacists in the “Ending the HIV Epidemic: A Plan for America” Initiative
Donna Hubbard McCree, Kathy K. Byrd, Marie Johnston, et al.
Public Health Reports (2020) Vol. 135, Iss. 5, pp. 547-554
Open Access | Times Cited: 43
Donna Hubbard McCree, Kathy K. Byrd, Marie Johnston, et al.
Public Health Reports (2020) Vol. 135, Iss. 5, pp. 547-554
Open Access | Times Cited: 43
HIV pre-exposure prophylaxis (PrEP) knowledge, familiarity, and attitudes among United States healthcare professional students: A cross-sectional study
Sarahmona Przybyla, Jennifer Fillo, Kimberly E. Kamper‐DeMarco, et al.
Preventive Medicine Reports (2021) Vol. 22, pp. 101334-101334
Open Access | Times Cited: 26
Sarahmona Przybyla, Jennifer Fillo, Kimberly E. Kamper‐DeMarco, et al.
Preventive Medicine Reports (2021) Vol. 22, pp. 101334-101334
Open Access | Times Cited: 26
Small-area spatial-temporal changes in pre-exposure prophylaxis (PrEP) use in the general population and among men who have sex with men in the United States between 2012 and 2018
Farah Mouhanna, Amanda D. Castel, Patrick S. Sullivan, et al.
Annals of Epidemiology (2020) Vol. 49, pp. 1-7
Closed Access | Times Cited: 17
Farah Mouhanna, Amanda D. Castel, Patrick S. Sullivan, et al.
Annals of Epidemiology (2020) Vol. 49, pp. 1-7
Closed Access | Times Cited: 17
Support and perceived barriers to implementing pre-exposure prophylaxis screening and dispensing in pharmacies: Examining concordance between pharmacy technicians and pharmacists
Roderick Hopkins, Dorie Josma, Joseph Morris, et al.
Journal of the American Pharmacists Association (2020) Vol. 61, Iss. 1, pp. 115-120
Closed Access | Times Cited: 17
Roderick Hopkins, Dorie Josma, Joseph Morris, et al.
Journal of the American Pharmacists Association (2020) Vol. 61, Iss. 1, pp. 115-120
Closed Access | Times Cited: 17
Do we Still Need Eligibility Criteria to Recommend PrEP? Impact of National Prescribing Requirements on Retention in Care and Sexually Transmitted Infections Acquisition
Roberto Rossotti, Alessandro Tavelli, D Calzavara, et al.
AIDS and Behavior (2024) Vol. 28, Iss. 7, pp. 2258-2263
Closed Access | Times Cited: 1
Roberto Rossotti, Alessandro Tavelli, D Calzavara, et al.
AIDS and Behavior (2024) Vol. 28, Iss. 7, pp. 2258-2263
Closed Access | Times Cited: 1
Process description of developing HIV prevention monitoring indicators for a province-wide pre-exposure prophylaxis (PrEP) program in British Columbia, Canada
Lalani L. Munasinghe, Junine Toy, Katherine J. Lepik, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0283025-e0283025
Open Access | Times Cited: 3
Lalani L. Munasinghe, Junine Toy, Katherine J. Lepik, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0283025-e0283025
Open Access | Times Cited: 3
Implementation of Sexual Health Curriculum Series: Educational Initiative to Increase STI Screening and Treatment in Dallas, Texas
Helen King, Eunsol Park, Hannah Blanchard, et al.
Journal of Community Health (2023) Vol. 48, Iss. 5, pp. 793-797
Open Access | Times Cited: 3
Helen King, Eunsol Park, Hannah Blanchard, et al.
Journal of Community Health (2023) Vol. 48, Iss. 5, pp. 793-797
Open Access | Times Cited: 3
Missed opportunities for HIV pre‐exposure prophylaxis among people with recent HIV infection: The French ANRS 95041 OMaPrEP study
C. Lions, Hélène Laroche, Marion Mora, et al.
HIV Medicine (2022) Vol. 24, Iss. 2, pp. 191-201
Open Access | Times Cited: 4
C. Lions, Hélène Laroche, Marion Mora, et al.
HIV Medicine (2022) Vol. 24, Iss. 2, pp. 191-201
Open Access | Times Cited: 4
Correlates of pre-exposure prophylaxis (PrEP) use among college students in the United States
John Ferrand, Brian Dodge, Heather Eastman‐Mueller, et al.
Journal of HIV/AIDS & Social Services (2024), pp. 1-22
Closed Access
John Ferrand, Brian Dodge, Heather Eastman‐Mueller, et al.
Journal of HIV/AIDS & Social Services (2024), pp. 1-22
Closed Access
A qualitative study on the clinical safety and user experiences of female condoms for anal intercourse among men who have sex with men in Shanghai, China
Jialu Huang, Xin Xin, Mingjun Ma, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 1
Jialu Huang, Xin Xin, Mingjun Ma, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 1
The Italian PrEPventHIV challenge: a scoping systematic review on HIV pre-exposure prophylaxis monitoring in Italy.
Pietro Ferrara, Vincenza Gianfredi
PubMed (2022) Vol. 93, Iss. 3, pp. e2022164-e2022164
Closed Access | Times Cited: 2
Pietro Ferrara, Vincenza Gianfredi
PubMed (2022) Vol. 93, Iss. 3, pp. e2022164-e2022164
Closed Access | Times Cited: 2
Inflammatory cytologic alterations in the oral epithelium associated with HIV pre-exposure prophylaxis: a preliminary study
Gabriela Leite BAGGIO, Nayara Flores MACEDO, Júlio Cezar Merlin, et al.
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology (2021) Vol. 131, Iss. 5, pp. 534-539
Closed Access | Times Cited: 2
Gabriela Leite BAGGIO, Nayara Flores MACEDO, Júlio Cezar Merlin, et al.
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology (2021) Vol. 131, Iss. 5, pp. 534-539
Closed Access | Times Cited: 2
PrEParing for Preexposure Prophylaxis
Michelle P. Zappas, Ruth Madden Foreman
Journal of Doctoral Nursing Practice (2020) Vol. 13, Iss. 1, pp. 3-8
Closed Access | Times Cited: 1
Michelle P. Zappas, Ruth Madden Foreman
Journal of Doctoral Nursing Practice (2020) Vol. 13, Iss. 1, pp. 3-8
Closed Access | Times Cited: 1
Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada
David Knox, Robert Pilarski, Harvinder S. Dhunna, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 1
David Knox, Robert Pilarski, Harvinder S. Dhunna, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 1
Differences in tenofovir trough concentrations between branded and generic formulations in people taking PrEP
Dario Cattaneo, Pietro Vinti, Sara Baldelli, et al.
AIDS (2021) Vol. 35, Iss. 3, pp. 522-524
Closed Access | Times Cited: 1
Dario Cattaneo, Pietro Vinti, Sara Baldelli, et al.
AIDS (2021) Vol. 35, Iss. 3, pp. 522-524
Closed Access | Times Cited: 1
Providing HIV pre-exposure prophylaxis to men who have sex with men and transgender women in hospitals and community-led clinics in Thailand: acceptance, patterns of use, trends in risk behaviors, and HIV incidence
L Cheewanan, M Chomnad, P Nittaya, et al.
AIDS Care (2023) Vol. 35, Iss. 4, pp. 524-537
Closed Access
L Cheewanan, M Chomnad, P Nittaya, et al.
AIDS Care (2023) Vol. 35, Iss. 4, pp. 524-537
Closed Access
HIV preexposure prophylaxis treatment patterns in a national health plan population
Jeremiah Rastegar, Amy Hu, Linda H. Chung, et al.
Journal of Managed Care & Specialty Pharmacy (2023) Vol. 29, Iss. 12, pp. 1267-1274
Open Access
Jeremiah Rastegar, Amy Hu, Linda H. Chung, et al.
Journal of Managed Care & Specialty Pharmacy (2023) Vol. 29, Iss. 12, pp. 1267-1274
Open Access
Narrowing down the causes of failure of tenofovir (only) for preexposure prophylaxis
Hope R. Lapointe, P. Richard Harrigan
AIDS (2019) Vol. 33, Iss. 15, pp. 2437-2438
Open Access
Hope R. Lapointe, P. Richard Harrigan
AIDS (2019) Vol. 33, Iss. 15, pp. 2437-2438
Open Access
HIV Pre-Exposure Prophylaxis (PrEP) Knowledge, Familiarity, and Attitudes among Healthcare Professional Students
Sarahmona Przybyla, Jennifer Fillo, Kimberly E. Kamper‐DeMarco, et al.
Research Square (Research Square) (2019)
Open Access
Sarahmona Przybyla, Jennifer Fillo, Kimberly E. Kamper‐DeMarco, et al.
Research Square (Research Square) (2019)
Open Access
Modelling Risk Behaviour: The use of Behaviour Change Assumptions in Cost-Effectiveness Studies for Oral PrEP in the United Kingdom and United States
Mona Koshkouei, Ryan Whitacre, Sara Paparini
Research Square (Research Square) (2022)
Open Access
Mona Koshkouei, Ryan Whitacre, Sara Paparini
Research Square (Research Square) (2022)
Open Access